학술논문
Atezolizumab (atezo) plus platinum/gemcitabine (plt/gem) vs placebo plus plt/gem for first-line (1L) treatment (tx) of locally advanced or metastatic urothelial carcinoma (mUC): Final OS from the randomized Phase 3 IMvigor130 study.
Document Type
Journal
Author
Galsky, Matt D.; Arija, Jose Angel Arranz; De Santis, Maria; Davis, Ian D.; Bamias, Aristotelis; Kikuchi, Eiji; del Muro, Xavier Garcia; Park, Se Hoon; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Puente, Javier; Li, Jian-Ri; O'Donnell, Peter H.; Bernhard, Sandrine; Lee, Chooi Peng; Bene-Tchaleu, Fabiola; Mariathasan, Sanjeev; Grande, Enrique
Source
Subject
Language
English
ISSN
15277755